There was a decrease in total pRb and phosphorylated pRb in both EGFR-TKI-sensitive and resistant NSCLC cells after treatment with PD 0332991 (8 μmol/L) for 24-48 hr (Figure 4A-4D). This evidence concerns the gene RB1 and non-small cell lung carcinoma.